ClinicalTrials.gov
public full text
Public Domain
Olanzapine in the Treatment of Patients With Anorexia Nervosa
The purpose of the study is to evaluate the efficacy of an anti-psychotic medication, Olanzapine, in achieving desired weight gain in patients identified as having Anorexia Nervosa, either restricting or binge/purge subtype. The study will also evaluate the possible beneficial effects of Olanzapine in reducing the severity of the obsessive and/or anxiety symptoms associated with this disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Olanzapine effectiveness on weight gain in anorexia nervosa patients: systematic review and meta-analysis.#213870
- Effectiveness of Atypical Antipsychotic Medication for Outpatients With Anorexia Nervosa#853756
- Olanzapine Anorexia Cachexia#918458
- Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment#969956
- Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects#904998
Record · ID 848127
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive